Andi Roy
@roylab-oxford.bsky.social did:plc:6wi2ynttkmi7qt2ulmq2knhi
Clinician Scientist and Professor of Paediatric Haematology at University of Oxford. Childhood Leukaemia Research Group, Oxford: Developmental haematopoiesis and leukaemia https://www.paediatrics.ox.ac.uk/research/paediatric-leukaemia-research-group
Bei Bluesky seit
- Follower
- 281
- Folgt
- 205
- Posts
- 71
- Tage in Ranglisten
- 0
Zusammenfassung
Andi Roy (@roylab-oxford.bsky.social) ist seit 15 November 2024 auf Bluesky. Das Konto hat 281 Follower, folgt 205 Konten und hat 71 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
New publication from the groups of Duncan Odom, Marieke Essers and myself: Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisons: Cell Genomics www.cell.com/cell-genomic... @dkfz.bsky.social
Post anzeigenCongratulations to Professor Beth Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology! https://www.imm.ox.ac.uk/news/psaila-2026-iseh-janet-rowley-award @rdm.ox.ac.uk @medsci.ox.ac.uk @ox.ac.uk
Post anzeigen🚨Two complementary preprints from our group reveal convergent mechanisms of inherited B-ALL predisposition. Check out this terrific work led by @larawahlster.bsky.social, @alneehus.bsky.social & #AndrewLee! www.biorxiv.org/content/10.6... www.biorxiv.org/content/10.6...
Post anzeigen🙏 Deeply honored to receive the 2026 Warren Alpert Prize! This award reflects the work by so many to enable transformative therapies for sickle cell disease and thalassemia, and the power of human genetics to reveal biology and guide new treatments! hms.harvard.edu/news/2026-wa...
Post anzeigenWe're proud to share that Blood has a JIF of 23.9 and continues its position as the most-cited journal in hematology, with 168,805 total citations in 2025. Blood Advances' JIF is 7.7. With 26,750 citations in 2025, it's among the top ten most cited hematology journals. #JCR2026
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.